Where's it on?
FDA · Drugs ·

Semaglutide-Glycine-Cyanocobalamin Injectable recall

PAYLESS COMPOUNDERS, LLC recalled Semaglutide-Glycine-Cyanocobalamin Injectable on April 22, 2026 because of lack of Assurance of Sterility. It was sold in OR.

Why it was recalled

Lack of Assurance of Sterility

What's recalled

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Quantity: 91 vials

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice